Inventiva S A Asset Turnover Ratio (IVA), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Inventiva S a   (NASDAQ: IVA)
 

Inventiva S A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Inventiva S A 's asset turnover ratio, the ratio that measures the ability of Inventiva S A 's assets to generate revenue, sequentially decreased to 0.05 in the fourth quarter (Dec 31 2025), which does not come as a surprise, as the Inventiva S A continue to experience difficult business climate.

Within sector 194 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3804.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IVA Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change 109.73 % 109.73 % 109.73 % 109.73 % 71.03 %
Y / Y Revenue Change -48.13 % - - - -41.13 %
Asset Turnover Ratio (TTM) 0.05 - - - 0.2
IVA's Total Ranking # 3804 # 0 # # #
Seq. Asset Change 0 % 0 % 0 % 109.73 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 195
Healthcare Sector # 559
Overall Market # 3804

Asset Turnover Ratio Statistics
High Average Low
0.58 0.24 0.05
(Dec 31 2023)   (Dec 31 2025)




IVA Company Profile • Back to IVA Efficiency Comparisons • Compare IVA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Proqr Therapeutics N v   0.14 $ 17.815  Millions$ 131.196  Millions
Voyager Therapeutics Inc   0.13 $ 40.374  Millions$ 303.983  Millions
Cannapharmarx Inc   0.13 $ 1.362  Millions$ 10.336  Millions
Biontech Se  0.13 $ 3,214.288  Millions$ 24,627.232  Millions
Royalty Pharma Plc  0.13 $ 2,378.193  Millions$ 18,724.829  Millions
Cervomed Inc   0.12 $ 4.007  Millions$ 32.537  Millions
Scisparc Ltd  0.12 $ 0.856  Millions$ 7.001  Millions
Kamada Ltd   0.12 $ 44.678  Millions$ 374.799  Millions
C4 Therapeutics Inc   0.12 $ 35.947  Millions$ 310.154  Millions
Lucid Diagnostics Inc   0.11 $ 4.706  Millions$ 41.277  Millions
Scinai Immunotherapeutics Ltd  0.11 $ 1.311  Millions$ 11.679  Millions
Autolus Therapeutics Plc  0.11 $ 75.388  Millions$ 679.584  Millions
Vystar Corporation  0.11 $ 0.055  Millions$ 0.498  Millions
Lipocine Inc   0.11 $ 1.977  Millions$ 18.039  Millions
Bolt Biotherapeutics Inc   0.11 $ 7.695  Millions$ 70.791  Millions
Seastar Medical Holding Corp  0.11 $ 1.234  Millions$ 11.417  Millions
Coherus Oncology inc   0.11 $ 42.172  Millions$ 396.348  Millions
Nuvation Bio Inc   0.11 $ 61.883  Millions$ 584.024  Millions
Petvivo Holdings Inc   0.10 $ 0.791  Millions$ 7.707  Millions
Adagene Inc   0.10 $ 7.671  Millions$ 75.327  Millions
Ocular Therapeutix Inc   0.10 $ 51.951  Millions$ 519.048  Millions
Beam Therapeutics Inc   0.10 $ 139.743  Millions$ 1,412.584  Millions
Viridian Therapeutics Inc   0.10 $ 70.835  Millions$ 719.985  Millions
Sintx Technologies Inc   0.10 $ 1.018  Millions$ 10.379  Millions
Eyepoint Inc   0.10 $ 31.371  Millions$ 319.851  Millions
Metagenomi Therapeutics Inc   0.10 $ 25.210  Millions$ 259.798  Millions
Kura Oncology Inc   0.10 $ 67.482  Millions$ 703.483  Millions
Renovorx Inc   0.09 $ 1.123  Millions$ 12.240  Millions
Bicycle Therapeutics Plc  0.09 $ 72.586  Millions$ 799.407  Millions
Insight Molecular Diagnostics Inc   0.09 $ 4.055  Millions$ 45.143  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.